Skip to Main Content

Evaxion Biotech A/S American Depositary Share

EVAX Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of EVAX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
EVAX Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
EVAX Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
EVAX Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by EVAX's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

EVAX Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
EVAX Income Statement
EVAX Balance Sheet
EVAX Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Proteins and nucleic acids useful in vaccines targeting Feb. 18, 2025
  • Patent Title: Chimeric proteins for inducing immunity towards infection with Jan. 28, 2025
  • Patent Title: Proteins and nucleic acids useful in vaccines targeting Jun. 11, 2024
  • Patent Title: Peptides derived from Jan. 02, 2024
  • Patent Title: Proteins and nucleic acids useful in vaccines targeting Nov. 07, 2023
  • Patent Title: Vaccines targeting Aug. 08, 2023
  • Patent Title: Chimeric proteins for inducing immunity towards infection with Aug. 16, 2022
  • Patent Title: Proteins and nucleic acids useful in vaccines targeting Jul. 06, 2021
  • Patent Title: Proteins and nucleic acids useful in vaccines targeting Mar. 16, 2021
  • Patent Title: Proteins and nucleic acids useful in vaccines targeting Dec. 01, 2020
  • Patent Title: Proteins and nucleic acids useful in vaccines targeting Jun. 09, 2020
  • Patent Title: Proteins and nucleic acids useful in vaccines targeting Oct. 08, 2019
  • Patent Title: Proteins and nucleic acids useful in vaccines targeting Jul. 31, 2018
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
EVAX News

Recent insights relating to EVAX

CNBC Recommendations

Recent picks made for EVAX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in EVAX

EVAX Analyst Ratings

EVAX Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
EVAX Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $EVAX stock a Buy, Sell, or Hold?

  • What is the price target for $EVAX stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

EVAX Top Shareholders
Shareholder
Shares Held
EVAX Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $EVAX stock?

  • Who owns the most shares of $EVAX stock?

  • What funds own $EVAX stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

EVAX Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view EVAX Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top